ARTICLE
Promoting real-world evidence use for antimicrobial stewardship in Latin America: evaluation of impact of a two-part educational webinar series
Background
Educational programs on the use of real-world evidence (RWE) in antimicrobial stewardship (AMS) are scarce in Latin America (LATAM).
Objectives
To develop and evaluate an online educational program supporting LATAM healthcare professionals (HCP)’s ability to use and generate RWE for effective antimicrobial agent use, aligned with AMS principles.
Methods
Two 90-min webinars were developed by subject matter experts. Changes in knowledge, skills, confidence and attitudes were measured via paired PRE-and POST-intervention survey questions. Satisfaction, intent to change and remaining barriers were surveyed POST-intervention. McNemar and Wilcoxon Signed Rank statistical tests assessed differences in paired dichotomous and ordinal data, respectively. Unpaired data underwent descriptive analysis. Open-ended responses were subject to thematic content analysis (inductive reasoning approach).
Results
The analysis sample included 741 PRE-intervention survey completers (epidemiologists, infection control specialists, chemists, pharmacists, biologists, microbiologists, bacteriologists and other physicians), with 47 completing the full POST survey (33 following webinar 1, and 14 following webinar 2). A significant increase in the percent of completers who were confident of ‘what constitutes RWE’ was found PRE (31%) to POST (73%) intervention (P < 0.001). Median self-reported skill levels changed from ‘2-basic’ to ‘3-intermediate’ for providing examples of RWE and applying RWE in the context of AMS (P < 0.05). Barriers included low perceived value of RWE by administrators and limited access to appropriate data.
Conclusions
This education improved HCPs’ confidence in knowing what constitutes RWE. Findings provide direction for future interventions aimed at enhancing access to and appropriate use of RWE to inform AMS in LATAM.
CONFERENCE
AIS (Alliance Industry Summit) 2024
At this year’s AIS conference in Philadelphia, on September 17, 2024, AXDEV CEO & Founder, Suzanne Murray, presented and explored best practices, and errors, in Needs Assessment, that best inform Instructional Design and Program Evaluation.
This was a very engaging session, where the audience was invited to interact and learn more about this topic.
CONFERENCE
Showcasing Success: Disseminating Your Work Matters
ACEHP (Alliance for Continuing Education in the Health Professions) September 12, 2024
This webinar addressed how to effectively disseminate your education and research through various channels (journals, professional societies, social media).
Presenters included our CEO & Founder, Suzanne Murray, Jacob Coverstone, David Price, Erin Schwarz, with our moderator Riaz Baxamusa
ARTICLE
Multidisciplinary Education and Action to Foster Equitable Cancer Care
Accepted for presention at the 2023 ASCO Quality of Care Symposium in Boston on October 27-28, 2023.
ARTICLE
Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France,Germany, and the United States
Published in BMC Cancer: Open access journal for cancer research.
This study was financially supported by educational research funds from
Eli Lilly & Company
CONFERENCE
Why are we only talking about OUTCOMES, when we should also be talking about IMPACT?
Accepted for presentation at the 17th Annual European CME Forum, 6–8 November, 2024 in Madrid, Spain.
CONFERENCE
Recognizing clinical manifestations of rare diseases: Knowledge and confidence gaps of HCPs can impact diagnosis and management of Fibrodysplasia Ossificans Progressiva (FOP)
Accepted for presentation at the 2024 NORD Rare Diseases & Orphan Products Breakthrough Summit, October 20-22 2024 in Washington DC.
CONFERENCE
Adaptive learning to address gaps in metastatic breast cancer treatment with CDK 4/6 inhibitors
Accepted for presentation at ASCO 2024 Quality Care Symposium in San Francisco on September 27-28.
Project was in collaboration with Antidote Education and funded by Pfizer
ARTICLE
Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers
Published in Liver International.
This project was supported through independent educational research funds from Pfizer.
